cariporide has been researched along with phosphocreatine in 2 studies
| Studies (cariporide) | Trials (cariporide) | Recent Studies (post-2010) (cariporide) | Studies (phosphocreatine) | Trials (phosphocreatine) | Recent Studies (post-2010) (phosphocreatine) |
|---|---|---|---|---|---|
| 409 | 10 | 79 | 7,475 | 329 | 575 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aye, NN; Hashimoto, K; Sawada, N; Sugiyama, A | 1 |
| Fukuhiro, Y; Ou, R; Pepe, S; Rosenfeldt, F; Wowk, M | 1 |
2 other study(ies) available for cariporide and phosphocreatine
| Article | Year |
|---|---|
Cariporide, a highly selective Na+/H+ exchange inhibitor, suppresses the reperfusion-induced lethal arrhythmias and "overshoot" phenomenon of creatine phosphate in situ rat heart.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Glucose; Blood Pressure; Coronary Vessels; Electrocardiography; Guanidines; Heart; Heart Rate; Male; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchangers; Sulfones; Ventricular Fibrillation | 1999 |
Cardioplegic strategies for calcium control: low Ca(2+), high Mg(2+), citrate, or Na(+)/H(+) exchange inhibitor HOE-642.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Calcium; Cardioplegic Solutions; Citric Acid; Guanidines; Heart; Heart Function Tests; In Vitro Techniques; Lactic Acid; Magnesium; Male; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sodium-Hydrogen Exchangers; Sulfones; Titrimetry | 2000 |